Journal article
Sugammadex in Ontario hospitals: Access and institutional policies
Abstract
RATIONALE AND AIMS: Sugammadex is a novel neuromuscular blockade reversal agent which rapidly reverses the effects of rocuronium and vecuronium. Compared with the first-generation neuromuscular blockade reversal agent, neostigmine, sugammadex has a number of superior properties; however, sugammadex is significantly more expensive per dose compared with neostigmine (~CAD$95 vs $4). Given the high cost of sugammadex, many Ontario hospitals either …
Authors
Cohen JC; Latchford KJ
Journal
Journal of Evaluation in Clinical Practice, Vol. 26, No. 1, pp. 50–55
Publisher
Wiley
Publication Date
2 2020
DOI
10.1111/jep.13151
ISSN
1356-1294